Peter Jeffrey Conn
Direttore/Membro del Consiglio presso Appello Pharmaceuticals, Inc.
Profilo
Peter Jeffrey Conn is the founder of Karuna Therapeutics, Inc. which was founded in 2009.
Currently, he holds a position as a Director at Appello Pharmaceuticals, Inc.
Posizioni attive di Peter Jeffrey Conn
| Società | Posizione | Inizio |
|---|---|---|
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter Jeffrey Conn
| Società | Posizione | Fine |
|---|---|---|
| KARA THER | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |
- Borsa valori
- Insiders
- Peter Jeffrey Conn
